(Date:5/12/2008)...FirstCall/ -- Allied Healthcare Products,Inc. (Na...or the third,quarter ending March 31 fell 64 perce...share, to about $100,000 in the current quarter, o...increased by about $240,000 compared to the,third ...l and labor costs,this fiscal year eroded margins ...
(Date:5/12/2008)...assionate Heart, of System, WASHINGTON, May 12 ...ans Affairs (VA), the nation,s largest single empl...oring six of its top professionals., "VA nurses...ealth care,system," stated Secretary of Veterans A...putation comes from the personal, one-on-one inter...
(Date:5/12/2008)...rench . , Montreal, May 12, 2008 A team of res...n of sildenafil protects the heart in mice with Du...r. Christine Des Rosiers from the Universit de Mon...ation with Dr. Basil Petrof of the Research Instit...and Dr. Christian Deschepper of the Institut de re...
(Date:5/12/2008)...creased 25% for the 12 weeks ended March ..., May 12 /PRNewswire-FirstCall/ -- Matrixx,Initiat...ealthcare company,that develops and markets produc... better(R)," today announced its financial results...h 31, 2008., For the fourth quarter ended March 3...
Breaking Medicine News(10 mins):Health News:Allied Healthcare Net Falls on Manufacturing Delays 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 4Health News:Allied Healthcare Net Falls on Manufacturing Delays 5Health News:New approach to protect the hearts of patients with muscular dystrophy 2Health News:New approach to protect the hearts of patients with muscular dystrophy 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 2Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 4Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 5Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 6Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 7Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 8...illion people in the United States have type 1 dia...in-producing beta // cells in the pancreas. Intens... 1 diabetes reduce their risk of nerve damage. Res...pe 1 diabetes. Each participant was assigned to pr...
...ers more evidence that soy plays a part in cancer ...ones and also may contain high amounts of fiber.//...ast cancer and prostate cancer, researchers conduc...icial for endometrial cancer. Endometrial cancer i...
...tates, about 35,000 people will be diagnosed with ...est gets closer to an earlier and more// accurate ... out to be kidney cancer. Currently, the only way ...uted axial tomography scan or magnetic resonance i...
... world’s second leading cause of blindness. More t...d by glaucoma.//New research suggests doctors need...when screening people for glaucoma. Researchers sa...ve way to determine whether or not someone has ear...
Other Medicine News:Health News:Urine Test for Kidney Cancer 2(Date:5/12/2008)...swire-USNewswire/ -- The Alliance for Lupus,Resear...esolution,supporting the goals and ideals of Natio...ther,s Day. The resolution, introduced by Senators...ls on all Americans to take the,week of May 11th -...on,women,s health issues, and recognizes the impor...
(Date:5/12/2008)...ir function like a radio dial, not an on/off,light...disease may develop,late in life, MEMPHIS, Tenn...ildren,s,Research Hospital study shows that T cell... simple on/off switches to govern the cellular,mac...on. Rather, they,possess sophisticated molecular c...
(Date:5/12/2008)...urological recovery in severely-injured, acute ...th Cethrin, HOPKINTON, Mass., May 12 /PRNewswire-...q: ALSE ) today announced 12-month interim data,f...roprietary recombinant,protein that is being inves...sory function after spinal cord injury, or SCI. Th...
(Date:5/12/2008).../- Arbios Systems, Inc.,(OT...ompany has received,approval from the U.S. Food an...l Device Exemption ("IDE") to begin the pivotal cl... (outside the body) liver assist,device for blood ...m,chronic liver disease., "We are pleased to have...
Breaking Medicine Technology:Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Best use for popular CAD assessment procedure is misunderstood 16767 1Best use for popular CAD assessment procedure is misunderstood 16767 2Risk of Womens Heart Attack or Stroke Appears to Be Lowered by DASH Diet 16762 1Risk of Womens Heart Attack or Stroke Appears to Be Lowered by DASH Diet 16762 2Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 1776 1Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 1776 2Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 1776 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 1776 4Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 1776 5Elevated Urate Levels May Slow Parkinsons in Men 16760 1Elevated Urate Levels May Slow Parkinsons in Men 16760 2... Autism Association calls 2006 Pediatrics study fa...USNewswire/ -- New findings,presented yesterday at...ims that vaccines may play a role in the developme...resented data,suggesting a correlation between mer...evelopmental disorder (PDD), a form of autism,in ...
...inical development program of first-in-class CB1,a...t reduction and,avoid image as life-style drug , B...telligence,firm La Merie S.L. reported today that ...t Acomplia (rimonabant) has at least,five competit...re,in earlier phases of R&D. While Acomplia re...
Other Medicine Technology:Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: